1887

Abstract

Varicella represents the most widespread vaccine-preventable childhood infectious disease in Italy. The purpose of this retrospective study was to assess the burden of varicella in Italy and in three regions that first implemented universal varicella vaccination. Four data sources were analysed: statutory notification data, the National Hospital Discharge Database, mortality data, and the vaccination coverage reached in Sicilia, Veneto and Apulia. The incidence rates per 100 000 population were calculated using the Italian resident population provided by the Italian Institute of Statistics in 2001–2010. In 2001–2010, the mean annual incidence of notifications of varicella was 150.7 cases per 100 000 population, reaching 948.6 cases per 100 000 population in the paediatric age group. The annual incidence declined to 102.6 per 100 000 population in 2010. During the period considered, 20 295 hospitalizations for varicella were observed. The mean annual incidence was 3.4 per 100 000 population, reaching a minimum of 2.5 per 100 000 in 2009 and 2010. Of the hospitalizations, 68.4 % occurred in the paediatric age group. The median length of hospital stay was 4 days. During 2001–2003 and 2006–2010, 33 deaths were reported. In the three regions considered, vaccination coverage increased steadily, reaching 81.5 % in Sicily, 79.4 % in Veneto and 75.6 % in Apulia in 2010. During the same period, hospitalization and notification rates decreased significantly. This study demonstrated that varicella continues to represent a relevant health problem in Italy, especially in the paediatric age group. Data obtained from the three Italian regions that first introduced universal vaccination demonstrated that vaccination reduces the incidence of varicella and hospitalization rates.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000061
2015-11-01
2024-03-28
Loading full text...

Full text loading...

/deliver/fulltext/jmm/64/11/1387.html?itemId=/content/journal/jmm/10.1099/jmm.0.000061&mimeType=html&fmt=ahah

References

  1. Alfonsi V., D'Ancona F., Giambi C., Nacca G., Rota M. C. 2011; Regional Coordinators for Infectious Diseases and Vaccinations Current immunization policies for pneumococcal, meningococcal C, varicella and rotavirus vaccinations in Italy. Health Policy 103:176–183 [View Article][PubMed]
    [Google Scholar]
  2. Almuneef M., Memish Z. A., Balkhy H. H., Alotaibi B., Helmy M. 2006; Chickenpox complications in Saudi Arabia: is it time for routine varicella vaccination?. Int J Infect Dis 10:156–161 [View Article][PubMed]
    [Google Scholar]
  3. Azzari C., Massai C., Poggiolesi C., Indolfi G., Spagnolo G., De Luca M., Gervaso P., de Martino M., Resti M. 2007; Cost of varicella-related hospitalisations in an Italian paediatric hospital: comparison with possible vaccination expenses. Curr Med Res Opin 23:2945–2954 [View Article][PubMed]
    [Google Scholar]
  4. Baldo V., Baldovin T., Russo F., Busana M. C., Piovesan C., Bordignon G., Giliberti A., Trivello R. 2009; Varicella: epidemiological aspects and vaccination coverage in the Veneto Region. BMC Infect Dis 9:150 [View Article][PubMed]
    [Google Scholar]
  5. Banz K., Wagenpfeil S., Neiss A., Goertz A., Staginnus U., Vollmar J., Wutzler P. 2003; The cost-effectiveness of routine childhood varicella vaccination in Germany. Vaccine 21:1256–1267 [View Article][PubMed]
    [Google Scholar]
  6. Bilcke J., Ogunjimi B., Marais C., de Smet F., Callens M., Callaert K., van Kerschaver E., Ramet J., van Damme P., Beutels P. 2012; The health and economic burden of chickenpox and herpes zoster in Belgium. Epidemiol Infect 140:2096–2109 [View Article][PubMed]
    [Google Scholar]
  7. Bonanni P., Boccalini S., Bechini A., Banz K. 2008; Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: the burden of uncomplicated hospitalised cases. Vaccine 26:5619–5626 [View Article][PubMed]
    [Google Scholar]
  8. Bonanni P., Breuer J., Gershon A., Gershon M., Hryniewicz W., Papaevangelou V., Rentier B., Rümke H., Sadzot-Delvaux C. other authors 2009; Varicella vaccination in Europe – taking the practical approach. BMC Med 7:26 [View Article][PubMed]
    [Google Scholar]
  9. Bonhoeffer J., Baer G., Muehleisen B., Aebi C., Nadal D., Schaad U. B., Heininger U. 2005; Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents. Eur J Pediatr 164:366–370 [View Article][PubMed]
    [Google Scholar]
  10. Brisson M., Edmunds W. J., Law B., Gay N. J., Walld R., Brownell M., Roos L., De Serres G. 2001; Epidemiology of varicella zoster virus infection in Canada and the United Kingdom. Epidemiol Infect 127:305–314 [View Article][PubMed]
    [Google Scholar]
  11. Cameron J. C., Allan G., Johnston F., Finn A., Heath P. T., Booy R. 2007; Severe complications of chickenpox in hospitalised children in the UK and Ireland. Arch Dis Child 92:1062–1066 [View Article][PubMed]
    [Google Scholar]
  12. Carapetis J. R., Russell D. M., Curtis N. 2004; The burden and cost of hospitalised varicella and zoster in Australian children. Vaccine 23:755–761 [View Article][PubMed]
    [Google Scholar]
  13. Carrillo-Santisteve P., Lopalco P. L. 2014; Varicella vaccination: a laboured take-off. Clin Microbiol Infect20 (Suppl) 5:86–91 [View Article][PubMed]
    [Google Scholar]
  14. CDC 1996; Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 45:(RR-11)1–36[PubMed]
    [Google Scholar]
  15. Ciofi degli Atti M. L., Rota M. C., Mandolini D., Bella A., Gabutti G., Crovari P., Salmaso S. 2002; Assessment of varicella underreporting in Italy. Epidemiol Infect 128:479–484[PubMed]
    [Google Scholar]
  16. Coudeville L., Brunot A., Szucs T. D., Dervaux B. 2005; The economic value of childhood varicella vaccination in France and Germany. Value Health 8:209–222 [View Article][PubMed]
    [Google Scholar]
  17. de Melker H., Berbers G., Hahné S., Rümke H., van den Hof S., de Wit A., Boot H. 2006; The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination. Vaccine 24:3946–3952 [View Article][PubMed]
    [Google Scholar]
  18. Dubos F., Grandbastien B., Hue V., Martinot A., Hospital Network for Evaluating Management of Common Childhood Diseases. 2007; Epidemiology of hospital admissions for paediatric varicella infections: a one-year prospective survey in the pre-vaccine era. Epidemiol Infect 135:131–138 [View Article][PubMed]
    [Google Scholar]
  19. ECDC 2014 Varicella Vaccine in the European Union Stockholm: European Centre for Disease Prevention and Control;
    [Google Scholar]
  20. Enders G., Bolley I., Miller E., Cradock-Watson J., Ridehalgh M. 1994; Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 343:1548–1551 [View Article][PubMed]
    [Google Scholar]
  21. Fairley C. K., Miller E. 1996; Varicella-zoster virus epidemiology – a changing scene?. J Infect Dis 174 (Suppl 3:S314–S319 [View Article][PubMed]
    [Google Scholar]
  22. Gabutti G., Rota M. C., Guido M., De Donno A., Bella A., Ciofi degli Atti M. L., Crovari P., Seroepidemiology Group. 2008; The epidemiology of Varicella Zoster Virus infection in Italy. BMC Public Health 8:372[PubMed] [CrossRef]
    [Google Scholar]
  23. Gabutti G., Rota M. C., Bonato B., Pirani R., Turlà G., Cucchi A., Cavallaro A. 2012; Hospitalizations for pertussis in Italy, 1999–2009: analysis of the hospital discharge database. Eur J Pediatr 171:1651–1655 [View Article][PubMed]
    [Google Scholar]
  24. Giammanco G., Ciriminna S., Barberi I., Titone L., Lo Giudice M., Biasio L. R. 2009; Universal varicella vaccination in the Sicilian paediatric population: rapid uptake of the vaccination programme and morbidity trends over five years. Euro Surveill 14:19321[PubMed]
    [Google Scholar]
  25. Grimprel E., Levy C., de La Rocque F., Cohen R., Soubeyrand B., Caulin E., Derrough T., Lecuyer A., d'Athis P., Gaudelus J., Pediatricians Working Group. 2007; Paediatric varicella hospitalisations in France: a nationwide survey. Clin Microbiol Infect 13:546–549 [View Article][PubMed]
    [Google Scholar]
  26. Grose C. 2005; Varicella vaccination of children in the United States: assessment after the first decade 1995–2005. J Clin Virol 33:89–95 [View Article][PubMed]
    [Google Scholar]
  27. Guillén J. M., Gil-Prieto R., Alvaro A., Gil A. 2010; Burden of adult varicella hospitalizations in Spain (2001–2007). Hum Vaccin 6:659–663 [View Article][PubMed]
    [Google Scholar]
  28. Halloran M. E., Cochi S. L., Lieu T. A., Wharton M., Fehrs L. 1994; Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am J Epidemiol 140:81–104[PubMed]
    [Google Scholar]
  29. Hambleton S., Gershon A. A. 2005; Preventing varicella-zoster disease. Clin Microbiol Rev 18:70–80 [View Article][PubMed]
    [Google Scholar]
  30. Heininger U., Seward J. F. 2006; Varicella. Lancet 368:1365–1376 [View Article][PubMed]
    [Google Scholar]
  31. Liese J. G., Grote V., Rosenfeld E., Fischer R., Belohradsky B. H., v Kries R., ESPED Varicella Study Group. 2008; The burden of varicella complications before the introduction of routine varicella vaccination in Germany. Pediatr Infect Dis J 27:119–124 [View Article][PubMed]
    [Google Scholar]
  32. Lin F., Hadler J. L. 2000; Epidemiology of primary varicella and herpes zoster hospitalizations: the pre-varicella vaccine era. J Infect Dis 181:1897–1905 [View Article][PubMed]
    [Google Scholar]
  33. Lopez A. S., Zhang J., Brown C., Bialek S. 2011; Varicella-related hospitalizations in the United States, 2000–2006: the 1-dose varicella vaccination era. Pediatrics 127:238–245 [View Article][PubMed]
    [Google Scholar]
  34. Marin M., Güris D., Chaves S. S., Schmid S., Seward J. F., Advisory Committee on Immunization Practices, Centers for Disease Control and Prevention (CDC). 2007; Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 56:(RR-4)1–40[PubMed]
    [Google Scholar]
  35. Ministero della Salute Italia 2012 Piano Nazionale Prevenzione Vaccinale (PNPV) 2012–2014 Intesa Stato-Regioni del 22 febbraio 2012 G.U. Serie Generale, 60
    [Google Scholar]
  36. Nguyen H. Q., Jumaan A. O., Seward J. F. 2005; Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med 352:450–458 [View Article][PubMed]
    [Google Scholar]
  37. Quian J., Rüttimann R., Romero C., Dall'Orso P., Cerisola A., Breuer T., Greenberg M., Verstraeten T. 2008; Impact of universal varicella vaccination on 1-year-olds in Uruguay: 1997–2005. Arch Dis Child 93:845–850 [View Article][PubMed]
    [Google Scholar]
  38. Rentier B., Gershon A. A., European Working Group on Varicella. 2004; Consensus: varicella vaccination of healthy children – a challenge for Europe. Pediatr Infect Dis J 23:379–389 [View Article][PubMed]
    [Google Scholar]
  39. Sadzot-Delvaux C., Rentier B., Wutzler P., Asano Y., Suga S., Yoshikawa T., Plotkin S. A. 2008; Varicella vaccination in Japan, South Korea, and Europe. J Infect Dis 197:(Suppl 2)S185–S190 [View Article][PubMed]
    [Google Scholar]
  40. Scalia Tomba G., Manfredi P. 2013; Quantifying the re-exposure process to an infectious agent. Measles and varicella as examples. Math Biosci 245:31–39 [View Article][PubMed]
    [Google Scholar]
  41. Seward J. F., Watson B. M., Peterson C. L., Mascola L., Pelosi J. W., Zhang J. X., Maupin T. J., Goldman G. S., Tabony L. J., other authors. 2002; Varicella disease after introduction of varicella vaccine in the United States, 1995–2000. JAMA 287:606–611 [View Article][PubMed]
    [Google Scholar]
  42. Tafuri S., Gallone M. S., Cappelli M. G., Gallone M. F., Larocca A. M. V., Germinario C. 2014; A seroprevalence survey on varicella among adults in the vaccination era in Apulia (Italy). Vaccine 32:6544–6547 [View Article][PubMed]
    [Google Scholar]
  43. Theodoridou M., Laina I., Hadjichristodoulou C., Syriopoulou V. 2006; Varicella-related complications and hospitalisations in a tertiary pediatric medical center before vaccine introduction. Eur J Pediatr 165:273–274 [View Article][PubMed]
    [Google Scholar]
  44. Thiry N., Beutels P., Tancredi F., Romanò L., Zanetti A., Bonanni P., Gabutti G., Van Damme P. 2004; An economic evaluation of varicella vaccination in Italian adolescents. Vaccine 22:3546–3562 [View Article][PubMed]
    [Google Scholar]
  45. Tseng H. W., Liu C. C., Wang S. M., Yang Y. J., Huang Y. S. 2000; Complications of varicella in children: emphasis on skin and central nervous system disorders. J Microbiol Immunol Infect 33:248–252[PubMed]
    [Google Scholar]
  46. Unim B., Saulle R., Boccalini S., Taddei C., Ceccherini V., Boccia A., Bonanni P., La Torre G. 2013; Economic evaluation of Varicella vaccination: results of a systematic review. Hum Vaccin Immunother 9:1932–1942 [View Article][PubMed]
    [Google Scholar]
  47. Wharton M. 1996; The epidemiology of varicella-zoster virus infections. Infect Dis Clin North Am 10:571–581 [View Article][PubMed]
    [Google Scholar]
  48. WHO 2014; Varicella and herpes zoster vaccines: WHO position paper, June 2014. Wkly Epidemiol Rec 89:265–287[PubMed]
    [Google Scholar]
  49. Zhou F., Ortega-Sanchez I. R., Guris D., Shefer A., Lieu T., Seward J. F. 2008; An economic analysis of the universal varicella vaccination program in the United States. J Infect Dis 197 (Suppl 2:S156–S164 [View Article][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000061
Loading
/content/journal/jmm/10.1099/jmm.0.000061
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error